Edition:
United Kingdom

Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Capital Market

0.76USD
21 Jun 2019
Change (% chg)

-- (--)
Prev Close
$0.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,027,290
52-wk High
$3.58
52-wk Low
$0.50

About

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI)... (more)

Overall

Beta: 1.22
Market Cap(Mil.): $454.30
Shares Outstanding(Mil.): 118.31
Dividend: --
Yield (%): --

Financials

  AVEO.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -0.56 -- --
ROI: -166.61 8.90 13.82
ROE: -- 10.04 15.24

Earnings vs. Estimates